We successfully identified CCNA2, CCNB1, KIF2C, CEP55, MELK, CDC20, and CCNB2, as potential biomarkers for AD through transcriptomic and scRNA-seq data analysis. This evidence concerns the gene CCNB2 and Alzheimer disease.